Trulieve Donates $65,000 to Libby's Legacy Breast Cancer Foundation

Trulieve's third annual partnership with the Florida -based organization raised money for breast cancer awareness and other necessary health screenings for women

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company based in the United States announced today a donation of $65,000 to Libby's Legacy Breast Cancer Foundation ("Libby's Legacy"), an organization based in the Company's home state of Florida .

Libby's Legacy was founded in 2007 and provides comprehensive services to the underserved through education, mammograms, and patient navigation on the journey from diagnosis to survivorship. The organization works primarily with women who have been diagnosed with stage IV breast cancer and their families to offer support and guidance.

"At the core of our company values is compassionate care and we're proud to partner with an organization like Libby's Legacy," said Trulieve CEO Kim Rivers . "We started Trulieve because we wanted to help patients suffering from medical ailments and terminal illnesses like cancer find relief and healing with natural, effective, and powerful medications. We believe strongly in Libby's Legacy's mission to support, educate, and guide people suffering from breast cancer, and are proud to be long-standing partners with them."

"Our partnership with Trulieve has been a life-changer in so many ways. From providing our patients with education and access to medical cannabis, to funding breast health services and recovery, it's been incredible to show how plant-based medicine can be beneficial to prevention and recurrence," says Robin Maynard-Harris , founder of Libby's Legacy.

Over the past three years, Trulieve has donated a portion of proceeds from exclusive products during October's Breast Cancer Awareness Month to Libby's Legacy. With more than $165,000 donated, Trulieve and Libby's Legacy have been able to provide five months of breast health services, including mammograms, ultrasounds, MRIs, and biopsies, as well as more than 40 hours of patient advocacy, and delivery of six months of fresh produce to four recovery families.

To find out more information about Libby's Legacy and its mission, please visit https://libbyslegacy.org/ .

For more information on Trulieve, please visit www.Trulieve.com .

About Trulieve
Trulieve is a vertically integrated "seed-to-sale" company and is the first and largest fully licensed medical cannabis company in the State of Florida . Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida , as well as directly to patients via home delivery. Trulieve also operates in California , Massachusetts , and Connecticut . Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF.

To learn more about Trulieve, visit www.Trulieve.com .

Cision View original content: https://www.prnewswire.com/news-releases/trulieve-donates-65-000-to-libbys-legacy-breast-cancer-foundation-301167927.html

SOURCE Trulieve Cannabis Corp.

Cision View original content: https://www.newswire.ca/en/releases/archive/November2020/06/c0087.html

News Provided by Canada Newswire via QuoteMedia

The Conversation (0)
Cannabis buds on a wooden surface with Australian banknotes nearby.

Australia's Cannabis Import Quota Slashed Amid Surging Local Production

Australia’s Office of Drug Control (ODC) said the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board from 101 tonnes to 88 tonnes, Business of Cannabis reported.Over-projected demand and idle permits that limited operational flexibility were cited... Keep Reading...
Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
Field of cannabis plants under bright sunlight.

Cannabis Market Update: H1 2025 in Review

The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
Closeup of lush green cannabis leaves.

Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout

Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
Cannabis leaf over map of Australia.

A State-by-State Guide to Cannabis in Australia

Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...

Latest Press Releases

Related News